PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar
Use of Low-Dose Aspirin as Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults (from the National Health Interview Survey, 2012) - ScienceDirect
Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings | Irish Journal of Medical Science (1971 -)
Aspirin in the Modern Era of Cardiovascular Disease Prevention - Methodist DeBakey Cardiovascular J
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes - ScienceDirect
Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events
New guidelines on the prevention of cardiovascular conditions - Medical Conferences
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar - ScienceDirect
Guidelines on the use of Aspirin for Prevention of ASCVD - HealthDirect
Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events
Aspirin underused in secondary CVD prevention, especially in lower-income countries
Arguments for and against aspirin use in secondary prevention of CHD... | Download Table
A farewell to aspirin in primary prevention? | Nature Reviews Cardiology
Aspirin for Primary Prevention in Diabetes
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis - The Lancet
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: Recommendation Statement | AAFP
Aspirin Use for Primary Secondary Prevention: Critical Appraisal of What We Know and What We Don't | tctmd.com